Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells

By        

Molecular Medicine Reports, Vol. 7, Iss. 2, 2013-01 ,pp. : 425-430

Spandidos Publications

Access to resources Recommend Favorite

Berberine Exhibits Antitumor Effects in Human Ovarian Cancer Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 4, 2015-05 ,pp. : 511-516

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel - The Memorial Sloan-Kettering Cancer Center experience

By Dizon D.S.   Dupont J.   Anderson S.   Sabbatini P.   Hummer A.   Aghajanian C.   Spriggs D.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 584-590

Elsevier

Access to resources Recommend Favorite

The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells

By Fujiwara Jun   Sowa Yoshihiro   Horinaka Mano   Koyama Makoto   Wakada Miki   Miki Tsuneharu   Sakai Toshiyuki  

International Journal of Oncology, Vol. 40, Iss. 5, 2012-05 ,pp. : 1483-1491

Spandidos Publications

Access to resources Recommend Favorite

Targeting Ovarian Cancer-Initiating Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 2, 2010-02 ,pp. : 157-163

Bentham Science Publishers

Access to resources Recommend Favorite